Is it true about the 40% royalties to ino? I know effin posts bs sometimes but I was wondering about the merits of that comment. I like this stock but I def want all the information that's out there and being new to this would like to know where one would find such info.
no, its not true. INO owns stock in ONCS that's how they'll get there money. But lets say it is true, if we are talking a $300m melanoma market, a $600m MCC market, maybe $300m for T-cell, that's $1.2b in revenue a year, ONCS has a market cap now of less than $200m. Do the math
Also you don't invest in a P2 biotech company for the marketing, you do it for the science, what is the next stage? Once in P3 then you can worry about marketing as they will have an 80% chance of approval statistically